Scholars Central

Conference abstractPublished 30 Jan 2017

Assessment of adhesion response to 3D printed materials for ophthalmic device development

Authors: Alband M, Lee Rmh, Penny M, Brocchini S, Hilton S

University College London, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction & Aim: Glaucoma is the leading cause of irreversible visual impairment worldwide. Glaucoma surgical devices fail due to a scarring response that resulted in fibrous encapsulation surrounding the device preventing aqueous humor drainage. 3D printing technology has the potential to develop personalized ophthalmic devices or organs with improved cost effectiveness and productivity. Limited experimental data exists as to the biocompatibility response of 3D printed photopolymers. We performed cell adhesion and protein adsorption studies of 3D printed photopolymers compared to materials used in current ophthalmic devices (silicone, polytetrafluoroethylene (PTFE) and poly (methyl methacrylate) (PMMA)) to assess 3D printed materials as a potential route for ophthalmic device development. Methods: 3D printed materials (n=6) were developed using a high-resolution, desktop stereo-lithography (SLA) 3D printer and compared to materials used in current ophthalmic devices. Protein adsorption was quantified using a micro bicinchoninic acid (micro BCA) assay and fluorescein-conjugated bovine serum albumin (FITC-BSA) adsorption. Cell adhesion (monocytes, fibroblasts) was assessed using alamarBlue, CyQUANT and Live/Dead assays. Data were compared using a two-tailed unpaired t-test. Results: 3D printed materials demonstrated low cell adhesion and protein adsorption. Results were similar to those found with materials used in current ophthalmic devices (P>0.05). However, it was noted that 3D printed materials demonstrated increased cytotoxicity (P<0.05). Conclusion: 3D printed photopolymer materials demonstrated a similar biocompatibility response to currently used materials and may allow for the development of customizable ophthalmic devices or organs. Subsequent testing will determine the adhesion response to 3D printed materials containing anti-scarring agents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Alband M”
  • BylineArticles whose byline prints “Lee Rmh”
  • BylineArticles whose byline prints “Penny M”
  • BylineArticles whose byline prints “Brocchini S”
  • BylineArticles whose byline prints “Hilton S”